We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mereo Biopharma Group Plc | LSE:MPH | London | Ordinary Share | GB00BZ4G2K23 | ORD GBP0.003 (REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 26.50 | 26.00 | 27.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:2524M Marchpole Holdings PLC 12 June 2003 Marchpole Holdings plc ("Marchpole" or "the Company") Holdings in Company The Company has been notified that Michael Morris, following the transfer to him of 11,945,457 ordinary shares in the Company from Harold Tillman, now holds in aggregate 42,140,048 ordinary shares representing 35.0% of the issued share capital. Harold Tillman has notified the Company that, following the transfer, he no longer has a notifiable interest in the issued share capital other than as a member of a 'concert party' with Michael Morris. 12 June 2003 This information is provided by RNS The company news service from the London Stock Exchange END HOLEAAKAFFLDEFE
1 Year Mereo Biopharma Chart |
1 Month Mereo Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions